Related Experiment Videos
The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia
1Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA.
Abstract:
The Raf/MEK/ERK (MAPK) signal transduction cascade is a vital mediator of a number of cellular fates including growth, proliferation and survival, among others. The focus of this review centers on the MAPK signal transduction pathway, its mechanisms of activation, downstream mediators of signaling, and the transcription factors that ultimately alter gene expression. Furthermore, negative regulators of this cascade, including phosphatases, are discussed with an emphasis placed upon chemotherapeutic intervention at various points along the pathway. In addition, mounting evidence suggests that the PI3K/Akt pathway may play a role in the effects elicited via MAPK signaling; as such, potential interactions and their possible cellular ramifications are discussed.
Insights
The Raf/MEK/ERK (MAPK) pathway regulates cell growth and survival. This review details its activation, regulation, and potential therapeutic targets, including interactions with the PI3K/Akt pathway.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Biochemistry
Background:
- The Raf/MEK/ERK (MAPK) pathway is crucial for cellular functions like growth, proliferation, and survival.
- Understanding this signaling cascade is key to deciphering cellular fate determination.
Purpose of the Study:
- To provide a comprehensive review of the MAPK signaling pathway.
- To explore its activation mechanisms, downstream effectors, and transcriptional regulation.
- To discuss negative regulators and potential chemotherapeutic interventions, including interactions with the PI3K/Akt pathway.
Main Methods:
- Literature review of scientific publications on MAPK signaling.
- Analysis of mechanisms of pathway activation and regulation.
- Examination of downstream signaling mediators and transcription factors.
- Investigation of negative regulators and their therapeutic potential.
- Exploration of cross-talk between MAPK and PI3K/Akt pathways.
Main Results:
- The MAPK pathway involves a series of kinases (Raf, MEK, ERK) that transmit signals from the cell surface to the nucleus.
- Downstream targets include transcription factors that control gene expression related to cell growth and survival.
- Phosphatases act as negative regulators, and targeting components of the pathway shows chemotherapeutic promise.
- The PI3K/Akt pathway may influence or be influenced by MAPK signaling, suggesting complex cellular regulation.
Conclusions:
- The MAPK pathway is a central regulator of cellular processes with significant implications for disease.
- Targeting the MAPK pathway offers a promising strategy for cancer chemotherapeutics.
- Further research into the interplay between MAPK and PI3K/Akt pathways is warranted to fully understand cellular signaling and develop effective treatments.